Silver Touch Q3 Profit Jumps 110% On Margin Expansion, AI Push

TECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Silver Touch Q3 Profit Jumps 110% On Margin Expansion, AI Push
Overview

Silver Touch Technologies posted a stellar Q3 FY26, with Profit After Tax surging 109.5% YoY to ₹11.02 Cr on revenue growth of 30.9% to ₹95.73 Cr. EBITDA soared 96.2% YoY to ₹19.09 Cr, driven by a significant 664 basis point expansion in EBITDA margin to 19.94%. This performance stems from a strategic pivot towards high-margin software, AI, and digital transformation services. The company also announced major order wins, including for the Indian Navy and Uttar Pradesh e-governance.

📉 The Financial Deep Dive

The Numbers: Silver Touch Technologies announced a robust Q3 FY26 performance. Revenue from operations climbed 30.9% YoY to ₹95.73 Cr. Profitability saw exceptional growth: EBITDA more than doubled, surging 96.2% YoY to ₹19.09 Cr. This surge was underpinned by a substantial EBITDA margin expansion of approximately 664 basis points, widening from 13.30% to 19.94%. Profit After Tax (PAT) recorded an even more dramatic increase of 109.51% YoY, reaching ₹11.02 Cr, with PAT margins improving by 383 basis points from 7.71% to 11.54%.

For the nine-month period (9M FY26), revenue grew 18.97% YoY to ₹242.47 Cr. EBITDA and PAT rose 64.78% and 73.42% respectively, with the EBITDA margin improving to 17.29% from 12.48% in 9M FY25.

The Quality: The significant expansion in both EBITDA and PAT margins highlights a material improvement in operational leverage and profitability. This is directly attributable to a strategic shift by the company. The leadership has emphasized a focus on high-margin software, AI-led solutions, and end-to-end digital transformation engagements. Client preference for AI-enabled platforms and data-driven solutions is enhancing revenue visibility and long-term stability.

The Grill: Management commentary points to increasing client preference for AI-enabled platforms and data-driven solutions as key growth drivers. They highlighted increasing revenue visibility and long-term stability. While specific analyst EPS vs. actuals are not provided, the quantum of PAT growth suggests a significant beat on expectations if any were set at this granular level.

🚩 Risks & Outlook

Specific Risks: A key area for monitoring is the company's financial leverage. While total assets grew by 40.8% to ₹243.17 Cr in FY25, total liabilities grew at a faster pace. This led to an increase in the debt-to-equity ratio from 0.53 to 0.82. Concurrently, finance costs saw a sharp jump of 92.6% YoY in Q3 FY26, indicating higher borrowing costs or increased debt servicing.

The Forward View: The company has outlined an ambitious outlook. Key initiatives include deepening its leadership in e-governance, significant investments in technology and innovation (AI, Cloud, Cybersecurity), and international expansion into the UK, Europe, USA, and Canada. The newly incorporated subsidiary, AI4Pharma Tech Ltd., signals a focused effort to scale AI offerings in the pharmaceutical sector globally. Investors will watch for successful execution of these expansion plans and continued margin improvement against the backdrop of rising finance costs.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.